| Filed | As-Of/On | Form | Fullname | Fund Class | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypotheticals Return |
Hypotheticals Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
History |
|---|
| 2009-07-02 | 2009-04-30 | N-CSRS | Dws Balanced Fund-Dws Balanced Fund | Flexible Portfolio | 17,100 | Added More | 6,600 | 62.85 % | $668,268 | $668,268 | $0 | 0.00 % | $0 | | | | | | History of Dws Balanced Fund-Dws Balanced Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-07-02 | 2009-04-30 | N-CSRS | Old Westbury Funds Inc-International Fund | International Multi-Cap Core | | Sold All | -2,800 | -100 % | | | | 0.00 % | $0 | | | | | | History of Old Westbury Funds Inc-International Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-07-02 | 2009-04-30 | N-CSRS | Riversource International Managers Series Inc-Riversource International Aggressive Growth Fund | International Multi-Cap Growth | 22,000 | Added More | 6,000 | 37.50 % | $859,760 | $859,760 | $0 | 0.00 % | $0 | | | | | | History of Riversource International Managers Series Inc-Riversource International Aggressive Growth Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-07-02 | 2009-03-31 | 13F-HR/A | Managed Account Advisors Llc | Institution | | Sold All | -9,148 | -100 % | | | | 0.00 % | $0 | | | | | | History of Managed Account Advisors Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-07-01 | 2009-04-30 | N-CSRS | Managers Trust I-Managers Fremont Global Fund | Global Flex Port | 1,600 | New Holding | 1,600 | 100 % | $63,312 | $62,528 | $-784 | -1.23 % | $-784 | | | | | | History of Managers Trust I-Managers Fremont Global Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-07-01 | 2009-04-30 | N-CSR | Mtb Group Of Funds-Mtb Small Cap Growth Fund | Small-Cap Growth | 32,266 | Added More | 12,766 | 65.46 % | $1,276,766 | $1,260,955 | $-15,810 | -1.23 % | $-6,255 | | | | | | History of Mtb Group Of Funds-Mtb Small Cap Growth Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-07-01 | 2009-04-30 | N-CSRS | Nationwide Mutual Funds-Nationwide Small Cap Index Fund | Small-Cap Core | | Sold All | -27,938 | -100 % | | | | -1.23 % | $13,690 | | | | | | History of Nationwide Mutual Funds-Nationwide Small Cap Index Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-07-01 | 2009-04-30 | N-CSRS | Russell Investment Co-Emerging Markets Fund | Emerging Markets | | Sold All | -3,600 | -100 % | | | | -1.23 % | $1,764 | | | | | | History of Russell Investment Co-Emerging Markets Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-07-01 | 2009-04-30 | N-CSRS | Russell Investment Co-International Fund | International Multi-Cap Core | 13,700 | Added More | 3,600 | 35.64 % | $542,109 | $535,396 | $-6,713 | -1.23 % | $-1,764 | | | | | | History of Russell Investment Co-International Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-07-01 | 2009-04-30 | N-CSRS | Vanguard Explorer Fund-Vanguard Explorer Fund | Small-Cap Growth | 455,917 | New Holding | 455,917 | 100 % | $18,040,636 | $17,817,236 | $-223,399 | -1.23 % | $-223,399 | | | | | | History of Vanguard Explorer Fund-Vanguard Explorer Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-30 | 2008-09-30 | 13F-HR/A | Russell Frank Co | Institution | 512,762 | Added More | 312,848 | 156.49 % | $21,079,646 | $20,038,739 | $-1,040,907 | -4.93 % | $-635,081 | | | | | | History of Russell Frank Co Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-29 | 2009-04-30 | N-Q | Advisors Inner Circle Fund Ii-Growth Fund | Small-Cap Growth | 39,620 | Added More | 5,510 | 16.15 % | $1,585,592 | $1,548,350 | $-37,243 | -2.34 % | $-5,179 | | | | | | History of Advisors Inner Circle Fund Ii-Growth Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-29 | 2009-04-30 | N-Q | Fidelity Advisor Series Vii-Fidelity Advisor Biotechnology Fund | Health/Biotech | 64,738 | Sold Some | -64,738 | -50.00 % | $2,590,815 | $2,529,961 | $-60,854 | -2.34 % | $60,854 | | | | | | History of Fidelity Advisor Series Vii-Fidelity Advisor Biotechnology Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-29 | 2009-04-30 | N-Q | Fidelity Advisor Series Vii-Fidelity Advisor Health Care Fund | Health/Biotech | 54,612 | Sold Some | -7,388 | -11.91 % | $2,185,572 | $2,134,237 | $-51,335 | -2.34 % | $6,945 | | | | | | History of Fidelity Advisor Series Vii-Fidelity Advisor Health Care Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-29 | 2009-04-30 | N-Q | Fidelity Devonshire Trust-Fidelity Mid Cap Growth Fund | Mid-Cap Growth | | Sold All | -39,000 | -100 % | | | | -2.34 % | $36,660 | | | | | | History of Fidelity Devonshire Trust-Fidelity Mid Cap Growth Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-29 | 2009-04-30 | N-Q | Fidelity Puritan Trust-Fidelity Balanced Fund | Flexible Portfolio | | Sold All | -542,600 | -100 % | | | | -2.34 % | $510,044 | | | | | | History of Fidelity Puritan Trust-Fidelity Balanced Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-29 | 2009-04-30 | N-Q | Fidelity Securities Fund-Otc Portfolio | Multi-Cap Growth | 360,960 | No Change | 0 | 0 % | $14,445,619 | $14,106,317 | $-339,302 | -2.34 % | $0 | | | | | | History of Fidelity Securities Fund-Otc Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-29 | 2009-04-30 | N-CSRS | Harbor Funds-Harbor Mid Cap Growth Fund | Mid-Cap Growth | | Sold All | -52,100 | -100 % | | | | -2.34 % | $48,974 | | | | | | History of Harbor Funds-Harbor Mid Cap Growth Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-29 | 2009-04-30 | N-CSRS | Harbor Funds-Harbor Small Cap Growth Fund | Small-Cap Growth | 283,880 | Sold Some | -6,700 | -2.30 % | $11,360,878 | $11,094,030 | $-266,847 | -2.34 % | $6,298 | | | | | | History of Harbor Funds-Harbor Small Cap Growth Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-29 | 2009-04-30 | N-CSRS | Harbor Funds-Harbor Small Company Growth Fund | Small-Cap Growth | 11,890 | Added More | 676 | 6.02 % | $475,838 | $464,661 | $-11,177 | -2.34 % | $-635 | | | | | | History of Harbor Funds-Harbor Small Company Growth Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-29 | 2009-04-30 | N-Q | Lord Abbett Developing Growth Fund Inc New-Lord Abbett Developing Growth Fund Inc New | Small-Cap Growth | 244,534 | New Holding | 244,534 | 100 % | $9,786,251 | $9,556,389 | $-229,862 | -2.34 % | $-229,862 | | | | | | History of Lord Abbett Developing Growth Fund Inc New-Lord Abbett Developing Growth Fund Inc New Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-29 | 2009-04-30 | N-Q | Lord Abbett Large Cap Growth Fund-Lord Abbett Large Cap Growth Fund | Large-Cap Growth | 51,412 | New Holding | 51,412 | 100 % | $2,057,508 | $2,009,181 | $-48,327 | -2.34 % | $-48,327 | | | | | | History of Lord Abbett Large Cap Growth Fund-Lord Abbett Large Cap Growth Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-29 | 2009-04-30 | N-Q | Northern Lights Fund Trust-Biondo Fund | Health/Biotech | 150 | New Holding | 150 | 100 % | $6,003 | $5,862 | $-141 | -2.34 % | $-141 | | | | | | History of Northern Lights Fund Trust-Biondo Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-29 | 2009-04-30 | N-Q | Northern Lights Fund Trust-Palantir Fund | Specialty & Misc | 14,000 | New Holding | 14,000 | 100 % | $560,280 | $547,120 | $-13,160 | -2.34 % | $-13,160 | | | | | | History of Northern Lights Fund Trust-Palantir Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-29 | 2009-04-30 | N-Q | Profunds-Bull Profund | Large-Cap Core | 3,948 | Added More | 2,884 | 271.05 % | $157,999 | $154,288 | $-3,711 | -2.34 % | $-2,711 | | | | | | History of Profunds-Bull Profund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-29 | 2009-04-30 | N-Q | Profunds-Health Care Ultrasector Profund | Health/Biotech | 170 | Sold Some | -65 | -27.65 % | $6,803 | $6,644 | $-160 | -2.34 % | $61 | | | | | | History of Profunds-Health Care Ultrasector Profund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-29 | 2009-04-30 | N-Q | Profunds-Technology Ultrasector Profund | Science & Tech | | Sold All | -6,815 | -100 % | | | | -2.34 % | $6,406 | | | | | | History of Profunds-Technology Ultrasector Profund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-29 | 2009-04-30 | N-Q | Usaa Mutual Funds Trust-Growth Fund | Multi-Cap Growth | 1,300 | New Holding | 1,300 | 100 % | $52,026 | $50,804 | $-1,222 | -2.34 % | $-1,222 | | | | | | History of Usaa Mutual Funds Trust-Growth Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-29 | 2009-04-30 | N-Q | Usaa Mutual Funds Trust-Small Cap Stock Fund | Small-Cap Core | 12,828 | Sold Some | -12,332 | -49.01 % | $513,377 | $501,318 | $-12,058 | -2.34 % | $11,592 | | | | | | History of Usaa Mutual Funds Trust-Small Cap Stock Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Janus Investment Fund-Janus Global Life Sciences Fund | Health/Biotech | 390,331 | Added More | 60,269 | 18.25 % | $15,211,199 | $15,254,135 | $42,936 | 0.28 % | $6,630 | | | | | | History of Janus Investment Fund-Janus Global Life Sciences Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-26 | 2009-04-30 | N-CSRS | Janus Investment Fund-Janus Global Technology Fund | Science & Tech | 47,745 | Added More | 13,110 | 37.85 % | $1,860,623 | $1,865,875 | $5,252 | 0.28 % | $1,442 | | | | | | History of Janus Investment Fund-Janus Global Technology Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-26 | 2009-04-30 | N-Q | Old Mutual Advisor Funds-Old Mutual Copper Rock Emerging Growth Fund | Small-Cap Growth | 8,812 | Sold Some | -17,088 | -65.97 % | $343,404 | $344,373 | $969 | 0.28 % | $-1,880 | | | | | | History of Old Mutual Advisor Funds-Old Mutual Copper Rock Emerging Growth Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-26 | 2009-04-30 | N-Q | Putnam Vista Fundnew-Putnam Vista Fundnew | Mid-Cap Growth | 13,959 | New Holding | 13,959 | 100 % | $543,982 | $545,518 | $1,535 | 0.28 % | $1,535 | | | | | | History of Putnam Vista Fundnew-Putnam Vista Fundnew Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-26 | 2009-04-30 | N-Q | Unamerica Series Trust-Balanced Portfolio | Flexible Portfolio | 470 | New Holding | 470 | 100 % | $18,316 | $18,368 | $52 | 0.28 % | $52 | | | | | | History of Unamerica Series Trust-Balanced Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-26 | 2009-04-30 | N-Q | Unamerica Series Trust-Growth Opportunities Portfolio | Multi-Cap Growth | 20,700 | No Compare | | | $806,679 | $808,956 | $2,277 | 0.28 % | | | | | | | History of Unamerica Series Trust-Growth Opportunities Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-26 | 2008-09-30 | 13F-HR/A | Legal And General Group Plc | Institution | | Sold All | -400 | -100 % | | | | 0.28 % | $-44 | | | | | | History of Legal And General Group Plc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-26 | 2008-06-30 | 13F-HR/A | Legal And General Group Plc | Institution | 400 | New Holding | 400 | 100 % | $15,588 | $15,632 | $44 | 0.28 % | $44 | | | | | | History of Legal And General Group Plc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-25 | 2009-04-30 | N-Q | Morgan Stanley Health Sciences Trust-None | Specialty & Misc | 7,739 | New Holding | 7,739 | 100 % | $317,531 | $302,440 | $-15,091 | -4.75 % | $-15,091 | | | | | | History of Morgan Stanley Health Sciences Trust-None Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-24 | 2009-04-30 | N-Q | Alliancebernstein Cap Fund Inc-Alliancebernstein Small Cap Growth Portfolio | Small-Cap Growth | 95,700 | Sold Some | -3,700 | -3.72 % | $3,725,601 | $3,739,956 | $14,355 | 0.38 % | $-555 | | | | | | History of Alliancebernstein Cap Fund Inc-Alliancebernstein Small Cap Growth Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-24 | 2009-04-30 | N-Q | Alliancebernstein Mid Cap Growth Fund Inc-Alliancebernstein Mid Cap Growth Fund Inc | Mid-Cap Growth | 136,300 | Sold Some | -23,400 | -14.65 % | $5,306,159 | $5,326,604 | $20,445 | 0.38 % | $-3,510 | | | | | | History of Alliancebernstein Mid Cap Growth Fund Inc-Alliancebernstein Mid Cap Growth Fund Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-24 | 2009-04-30 | N-Q | Alliancebernstein Portfolios-Alliancebernstein Growth Fund | Multi-Cap Growth | | Sold All | -212,500 | -100 % | | | | 0.38 % | $-31,875 | | | | | | History of Alliancebernstein Portfolios-Alliancebernstein Growth Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-23 | 2009-06-19 | 4 | Hallal David | No Data | 19,121 | Sold Some | -789 | -3.96 % | $717,802 | $747,249 | $29,446 | 4.10 % | $-1,215 | | X | | | Sr Vp Comm Ops Americas | History of Hallal David Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-23 | 2009-04-30 | N-CSRS | Oppenheimer Emerging Growth Fund-Oppenheimer Emerging Growth Fund | Small-Cap Growth | 42,990 | New Holding | 42,990 | 100 % | $1,613,845 | $1,680,049 | $66,205 | 4.10 % | $66,205 | | | | | | History of Oppenheimer Emerging Growth Fund-Oppenheimer Emerging Growth Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-23 | 2009-03-31 | 13F-HR/A | Ing Groep Nv | Institution | 115,400 | Added More | 8,500 | 7.95 % | $4,332,116 | $4,509,832 | $177,716 | 4.10 % | $13,090 | | | | | | History of Ing Groep Nv Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-19 | 2009-06-19 | 4 | Norby R Dougla | Insider | 31,089 | Added More | 20,000 | -224.44 % | $1,197,237 | $1,214,958 | $17,721 | 1.48 % | $11,400 | X | | | | | History of Norby R Dougla Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-19 | 2009-06-19 | 4 | Norby R Dougla | Insider | 11,089 | Sold Some | -20,000 | -64.33 % | $427,037 | $433,358 | $6,321 | 1.48 % | $-11,400 | X | | | | | History of Norby R Dougla Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-19 | 2009-04-30 | N-CSRS | Oppenheimer Midcap Fund-Oppenheimer Midcap Fund | Mid-Cap Core | 213,000 | New Holding | 213,000 | 100 % | $8,202,630 | $8,324,040 | $121,410 | 1.48 % | $121,410 | | | | | | History of Oppenheimer Midcap Fund-Oppenheimer Midcap Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-12 | 2009-06-11 | 4 | Hallal David | No Data | 19,910 | Sold Some | -3,590 | -15.27 % | $782,264 | $778,083 | $-4,181 | -0.53 % | $754 | | X | | | Sr Vp Comm Ops Americas | History of Hallal David Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-10 | 2009-03-31 | N-CSR | Ti Classic Funds-Small Cap Growth Stock Fund | Small-Cap Growth | 132,048 | Sold Some | -17,790 | -11.87 % | $4,928,031 | $5,160,436 | $232,404 | 4.71 % | $-31,310 | | | | | | History of Ti Classic Funds-Small Cap Growth Stock Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-10 | 2009-03-31 | N-CSR | Value Line Asset Allocation Fund Inc-Value Line Asset Allocation Fund Inc | Mixed-Asset Target Allocation Growth | 9,000 | No Change | 0 | 0 % | $335,880 | $351,720 | $15,840 | 4.71 % | $0 | | | | | | History of Value Line Asset Allocation Fund Inc-Value Line Asset Allocation Fund Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-10 | 2009-03-31 | N-CSR | Value Line Emerging Opportunities Fund Inc-Value Line Emerging Opportunities Fund Inc | Small-Cap Growth | 118,000 | No Change | 0 | 0 % | $4,403,760 | $4,611,440 | $207,680 | 4.71 % | $0 | | | | | | History of Value Line Emerging Opportunities Fund Inc-Value Line Emerging Opportunities Fund Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-10 | 2009-03-31 | N-CSR | Wisdomtree Trust-Wisdomtree Diefa Fund | Specialty & Misc | 103 | Added More | 12 | 13.18 % | $3,844 | $4,025 | $181 | 4.71 % | $21 | | | | | | History of Wisdomtree Trust-Wisdomtree Diefa Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-09 | 2009-03-31 | N-CSR | Assetmark Funds-Assetmark Large Cap Growth Fund | Large-Cap Growth | | Sold All | -11,848 | -100 % | | | | 3.14 % | $-14,099 | | | | | | History of Assetmark Funds-Assetmark Large Cap Growth Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-09 | 2009-03-31 | 13F-HR/A | Delaware Management Business Trust | Institution | 47,400 | Sold Some | -21,950 | -31.65 % | $1,795,986 | $1,852,392 | $56,406 | 3.14 % | $-26,121 | | | | | | History of Delaware Management Business Trust Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-09 | 2009-03-31 | N-CSRS | Ei Institutional Managed Trust-Small Cap Growth Fund | Small-Cap Growth | 64,880 | Added More | 41,553 | 178.13 % | $2,458,303 | $2,535,510 | $77,207 | 3.14 % | $49,448 | | | | | | History of Ei Institutional Managed Trust-Small Cap Growth Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-09 | 2009-03-31 | N-Q/A | Forum Funds-Adams Harkness Small Cap Growth Fund | Small-Cap Growth | 1,495 | Sold Some | -205 | -12.05 % | $56,646 | $58,425 | $1,779 | 3.14 % | $-244 | | | | | | History of Forum Funds-Adams Harkness Small Cap Growth Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-09 | 2009-03-31 | N-CSR | Nicholas Applegate Institutional Funds-International Growth Fund | Multi-Cap Growth | 4,730 | Sold Some | -1,670 | -26.09 % | $179,220 | $184,848 | $5,629 | 3.14 % | $-1,987 | | | | | | History of Nicholas Applegate Institutional Funds-International Growth Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-09 | 2009-03-31 | N-CSRS | Northern Lights Fund Trust-Biondo Fund | Health/Biotech | | Sold All | -150 | -100 % | | | | 3.14 % | $-179 | | | | | | History of Northern Lights Fund Trust-Biondo Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-08 | 2009-03-31 | N-CSR | Easons Series Trust-Mid Cap Growth Portfolio | Mid-Cap Growth | | Sold All | -8,800 | -100 % | | | | 6.95 % | $-22,352 | | | | | | History of Easons Series Trust-Mid Cap Growth Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-08 | 2009-03-31 | N-CSRS | Mallcap World Fund Inc-Smallcap World Fund Inc | Small-Cap Core | 300,000 | No Change | 0 | 0 % | $10,962,000 | $11,724,000 | $762,000 | 6.95 % | $0 | | | | | | History of Mallcap World Fund Inc-Smallcap World Fund Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-08 | 2009-03-31 | N-CSR | Pacific Life Funds-Pl Comstock Fund | Specialty & Misc | 8,950 | No Change | 0 | 0 % | $327,033 | $349,766 | $22,733 | 6.95 % | $0 | | | | | | History of Pacific Life Funds-Pl Comstock Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-08 | 2009-03-31 | N-CSRS | Touchstone Funds Group Trust-Touchstone Healthcare And Biotechnology Fund | Health/Biotech | 48,980 | Added More | 32,580 | 198.65 % | $1,789,729 | $1,914,138 | $124,409 | 6.95 % | $82,753 | | | | | | History of Touchstone Funds Group Trust-Touchstone Healthcare And Biotechnology Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-08 | 2009-03-31 | N-CSRS | Turner Funds-Turner Emerging Growth Fund | Small-Cap Growth | 257,610 | Added More | 53,790 | 26.39 % | $9,413,069 | $10,067,399 | $654,329 | 6.95 % | $136,627 | | | | | | History of Turner Funds-Turner Emerging Growth Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-08 | 2009-03-31 | N-CSRS | Turner Funds-Turner Large Cap Growth Fund | Large-Cap Growth | | Sold All | -259,117 | -100 % | | | | 6.95 % | $-658,157 | | | | | | History of Turner Funds-Turner Large Cap Growth Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-08 | 2009-03-31 | N-CSRS | Turner Funds-Turner New Enterprise Fund | Science & Tech | | Sold All | -13,010 | -100 % | | | | 6.95 % | $-33,045 | | | | | | History of Turner Funds-Turner New Enterprise Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-08 | 2009-03-31 | N-CSRS | Turner Funds-Turner Small Cap Growth Fund | Small-Cap Growth | 87,638 | Added More | 7,060 | 8.76 % | $3,202,293 | $3,424,893 | $222,601 | 6.95 % | $17,932 | | | | | | History of Turner Funds-Turner Small Cap Growth Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-08 | 2009-03-31 | N-CSRS | Turner Funds-Turner Strategic Growth Fund | Multi-Cap Growth | 249,997 | Sold Some | -11,983 | -4.57 % | $9,134,890 | $9,769,883 | $634,992 | 6.95 % | $-30,437 | | | | | | History of Turner Funds-Turner Strategic Growth Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-05 | 2009-06-04 | 4 | Dubin Thomas I H | Insider | 12,593 | Sold Some | -10,000 | -44.26 % | $468,711 | $492,134 | $23,423 | 4.99 % | $-18,600 | | X | | | Svp General Counsel | History of Dubin Thomas I H Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | 13F-HR/A | Amvescap Plc | Institution | 76,700 | Added More | 35,021 | 84.02 % | $2,854,774 | $2,997,436 | $142,662 | 4.99 % | $65,139 | | | | | | History of Amvescap Plc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSRS | Calvert Social Index Series Inc-Calvert Social Index Fund | Multi-Cap Core | 1,259 | New Holding | 1,259 | 100 % | $46,860 | $49,202 | $2,342 | 4.99 % | $2,342 | | | | | | History of Calvert Social Index Series Inc-Calvert Social Index Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Ishares Trust-Ishares Nasdaq Biotechnology Index Fund | Health/Biotech | 788,796 | Sold Some | -23,607 | -2.90 % | $29,358,987 | $30,826,148 | $1,467,161 | 4.99 % | $-43,909 | | | | | | History of Ishares Trust-Ishares Nasdaq Biotechnology Index Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Ishares Trust-Ishares Russell 2000 Growth Index Fund | Multi-Cap Growth | 555,218 | Added More | 15,210 | 2.81 % | $20,665,214 | $21,697,919 | $1,032,705 | 4.99 % | $28,291 | | | | | | History of Ishares Trust-Ishares Russell 2000 Growth Index Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Ishares Trust-Ishares Russell 2000 Index Fund | Specialty & Misc | 1,011,099 | Sold Some | -119,563 | -10.57 % | $37,633,105 | $39,513,749 | $1,880,644 | 4.99 % | $-222,387 | | | | | | History of Ishares Trust-Ishares Russell 2000 Index Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Ishares Trust-Ishares Russell 3000 Growth Index Fund | Multi-Cap Growth | 5,553 | Sold Some | -1,591 | -22.27 % | $206,683 | $217,011 | $10,329 | 4.99 % | $-2,959 | | | | | | History of Ishares Trust-Ishares Russell 3000 Growth Index Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Ishares Trust-Ishares Russell 3000 Index Fund | Specialty & Misc | 21,646 | Sold Some | -4,127 | -16.01 % | $805,664 | $845,926 | $40,262 | 4.99 % | $-7,676 | | | | | | History of Ishares Trust-Ishares Russell 3000 Index Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Mgi Funds-Mgi Us Large Cap Value Equity Fund | Large-Cap Value | | Sold All | -60,102 | -100 % | | | | 4.99 % | $-111,790 | | | | | | History of Mgi Funds-Mgi Us Large Cap Value Equity Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Rainier Investment Management Mutual Funds-Rainier Mid Cap Equity Portfolio | Mid-Cap Core | 25,125 | New Holding | 25,125 | 100 % | $935,153 | $981,885 | $46,733 | 4.99 % | $46,733 | | | | | | History of Rainier Investment Management Mutual Funds-Rainier Mid Cap Equity Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Rydex Series Funds-Absolute Return Strategies Fund | Equity Mkt Neutral Funds | | Sold All | -430 | -100 % | | | | 4.99 % | $-800 | | | | | | History of Rydex Series Funds-Absolute Return Strategies Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Rydex Series Funds-Banking Fund | Financial Services | 2,603 | Sold Some | -660 | -20.22 % | $96,884 | $101,725 | $4,842 | 4.99 % | $-1,228 | | | | | | History of Rydex Series Funds-Banking Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Rydex Series Funds-Biotechnology Fund | Health/Biotech | 60,140 | Added More | 2,400 | 4.15 % | $2,238,411 | $2,350,271 | $111,860 | 4.99 % | $4,464 | | | | | | History of Rydex Series Funds-Biotechnology Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Rydex Series Funds-Health Care Fund | Health/Biotech | | Sold All | -4,441 | -100 % | | | | 4.99 % | $-8,260 | | | | | | History of Rydex Series Funds-Health Care Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | N-CSR | Rydex Series Funds-Sector Rotation Fund | Multi-Cap Core | 31,500 | Added More | 1,000 | 3.27 % | $1,172,430 | $1,231,020 | $58,590 | 4.99 % | $1,860 | | | | | | History of Rydex Series Funds-Sector Rotation Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-05 | 2009-03-31 | 13F-HR/A | Teachers Advisors Inc | Institution | 129,579 | Added More | 39,654 | 44.09 % | $4,822,930 | $5,063,947 | $241,017 | 4.99 % | $73,756 | | | | | | History of Teachers Advisors Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-04 | 2009-03-31 | 13F-HR/A | Jefferies Group Inc | Institution | 7,943 | Sold Some | -14,757 | -65.00 % | $297,783 | $310,412 | $12,629 | 4.24 % | $-23,464 | | | | | | History of Jefferies Group Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-03 | 2009-06-01 | 4 | Keiser David W | Insider | 199,546 | Added More | 15,250 | 9.02 % | $7,764,335 | $7,798,258 | $33,923 | 0.43 % | $2,593 | X | | | | | History of Keiser David W Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-03 | 2009-06-01 | 4 | Keiser David W | Insider | 159,546 | Sold Some | -1,800 | -1.11 % | $6,207,935 | $6,235,058 | $27,123 | 0.43 % | $-306 | X | | | | | History of Keiser David W Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-03 | 2009-06-01 | 4 | Keiser David W | Insider | 161,346 | Sold Some | -38,200 | -19.14 % | $6,277,973 | $6,305,402 | $27,429 | 0.43 % | $-6,494 | X | | | | | History of Keiser David W Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-03 | 2009-06-01 | 4 | Keiser David W | Insider | 161,986 | Added More | 2,440 | 1.55 % | $6,302,875 | $6,330,413 | $27,538 | 0.43 % | $415 | X | | | | | History of Keiser David W Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-03 | 2009-06-01 | 4 | Keiser David W | Insider | 166,796 | Added More | 4,810 | 3.06 % | $6,490,032 | $6,518,388 | $28,355 | 0.43 % | $818 | X | | | | | History of Keiser David W Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-03 | 2009-06-01 | 4 | Keiser David W | Insider | 184,296 | Added More | 17,500 | 11.72 % | $7,170,957 | $7,202,288 | $31,330 | 0.43 % | $2,975 | X | | | | | History of Keiser David W Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-03 | 2009-06-01 | 4 | Keiser David W | Insider | 149,546 | Sold Some | -10,000 | -6.26 % | $5,818,835 | $5,844,258 | $25,423 | 0.43 % | $-1,700 | X | | | | | History of Keiser David W Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-03 | 2009-03-31 | 13F-HR/A | Catapult Capital Management Llc | Institution | 42,000 | Sold Some | -38,000 | -47.50 % | $1,634,220 | $1,641,360 | $7,140 | 0.43 % | $-6,460 | | | | | | History of Catapult Capital Management Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-03 | 2009-03-31 | N-CSRS | Loomis Sayles Funds I-Loomis Sayles Bond Fund | Specialty & Misc | 18,083 | New Holding | 18,083 | 100 % | $703,610 | $706,684 | $3,074 | 0.43 % | $3,074 | | | | | | History of Loomis Sayles Funds I-Loomis Sayles Bond Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-03 | 2009-03-31 | N-CSRS | Loomis Sayles Funds Ii-Loomis Sayles Aggressive Growth Fund | Mid-Cap Growth | 34,673 | Sold Some | -10,381 | -23.04 % | $1,349,126 | $1,355,021 | $5,894 | 0.43 % | $-1,765 | | | | | | History of Loomis Sayles Funds Ii-Loomis Sayles Aggressive Growth Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-03 | 2009-03-31 | N-CSRS | Loomis Sayles Funds Ii-Loomis Sayles Small Cap Growth Fund | Small-Cap Growth | 18,083 | Sold Some | -700 | -3.72 % | $703,610 | $706,684 | $3,074 | 0.43 % | $-119 | | | | | | History of Loomis Sayles Funds Ii-Loomis Sayles Small Cap Growth Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-03 | 2009-03-31 | N-CSRS | Tiaa Cref Institutional Mutual Funds-Equity Index Fund | Specialty & Misc | 20,298 | Added More | 1,341 | 7.07 % | $789,795 | $793,246 | $3,451 | 0.43 % | $228 | | | | | | History of Tiaa Cref Institutional Mutual Funds-Equity Index Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-03 | 2009-03-31 | N-CSRS | Tiaa Cref Institutional Mutual Funds-Growth Equity Fund | Multi-Cap Growth | 29,163 | Added More | 5,503 | 23.25 % | $1,134,732 | $1,139,690 | $4,958 | 0.43 % | $936 | | | | | | History of Tiaa Cref Institutional Mutual Funds-Growth Equity Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-01 | 2009-03-31 | N-Q | Advanced Series Trust-Ast International Value Portfolio | Multi-Cap Value | 4,200 | New Holding | 4,200 | 100 % | $152,796 | $164,136 | $11,340 | 7.42 % | $11,340 | | | | | | History of Advanced Series Trust-Ast International Value Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-01 | 2009-03-31 | N-Q/A | Axa Premier Vip Trust-Multimanager Small Cap Growth Portfolio | Small-Cap Growth | 111,340 | Sold Some | -91,660 | -45.15 % | $4,050,549 | $4,351,167 | $300,618 | 7.42 % | $-247,482 | | | | | | History of Axa Premier Vip Trust-Multimanager Small Cap Growth Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-01 | 2009-03-31 | N-Q | Massmutual Select Funds-Massmutual Select Emerging Growth Fund | Small-Cap Growth | 12,300 | Sold Some | -20,400 | -62.38 % | $447,474 | $480,684 | $33,210 | 7.42 % | $-55,080 | | | | | | History of Massmutual Select Funds-Massmutual Select Emerging Growth Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-01 | 2009-03-31 | N-Q | Massmutual Select Funds-Massmutual Select Mid Cap Growth Equity Fund | Mid-Cap Growth | 8,600 | Sold Some | -4,300 | -33.33 % | $312,868 | $336,088 | $23,220 | 7.42 % | $-11,610 | | | | | | History of Massmutual Select Funds-Massmutual Select Mid Cap Growth Equity Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-01 | 2009-03-31 | N-Q | Massmutual Select Funds-Massmutual Select Mid Cap Growth Equity Ii Fund | Mid-Cap Growth | 103,000 | Added More | 18,900 | 22.47 % | $3,747,140 | $4,025,240 | $278,100 | 7.42 % | $51,030 | | | | | | History of Massmutual Select Funds-Massmutual Select Mid Cap Growth Equity Ii Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-01 | 2009-03-31 | N-Q | Massmutual Select Funds-Massmutual Select Small Cap Growth Equity Fund | Small-Cap Growth | | Sold All | -13,520 | -100 % | | | | 7.42 % | $-36,504 | | | | | | History of Massmutual Select Funds-Massmutual Select Small Cap Growth Equity Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-01 | 2009-03-31 | N-Q | Massmutual Select Funds-Massmutual Select Small Company Growth Fund | Small-Cap Growth | 5,810 | Added More | 490 | 9.21 % | $211,368 | $227,055 | $15,687 | 7.42 % | $1,323 | | | | | | History of Massmutual Select Funds-Massmutual Select Small Company Growth Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-01 | 2009-03-31 | N-Q | Massmutual Select Funds-Massmutual Select Strategic Balanced Fund | Mixed-Asset Target Allocation Moderate | 487 | Sold Some | -113 | -18.83 % | $17,717 | $19,032 | $1,315 | 7.42 % | $-305 | | | | | | History of Massmutual Select Funds-Massmutual Select Strategic Balanced Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-01 | 2009-03-31 | N-Q | Neuberger Berman Advisers Management Trust-Balanced Portfolio | Flexible Portfolio | 1,800 | Added More | 800 | 80.00 % | $65,484 | $70,344 | $4,860 | 7.42 % | $2,160 | | | | | | History of Neuberger Berman Advisers Management Trust-Balanced Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-01 | 2009-03-31 | N-Q | Neuberger Berman Advisers Management Trust-Growth Portfolio | Multi-Cap Growth | 88,700 | Added More | 37,700 | 73.92 % | $3,226,906 | $3,466,396 | $239,490 | 7.42 % | $101,790 | | | | | | History of Neuberger Berman Advisers Management Trust-Growth Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-01 | 2009-03-31 | N-Q | Rydex Dynamic Funds-Dynamic Russell 2000 Fund | No Data | 1,377 | New Holding | 1,377 | 100 % | $50,095 | $53,813 | $3,718 | 7.42 % | $3,718 | | | | | | History of Rydex Dynamic Funds-Dynamic Russell 2000 Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-01 | 2009-03-31 | N-Q | Rydex Variable Trust-Biotechnology Fund | Health/Biotech | 19,297 | Sold Some | -3,297 | -14.59 % | $702,025 | $754,127 | $52,102 | 7.42 % | $-8,902 | | | | | | History of Rydex Variable Trust-Biotechnology Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-01 | 2009-03-31 | N-Q | Rydex Variable Trust-Health Care Fund | Health/Biotech | | Sold All | -5,490 | -100 % | | | | 7.42 % | $-14,823 | | | | | | History of Rydex Variable Trust-Health Care Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-01 | 2009-03-31 | N-Q | Rydex Variable Trust-Sector Rotation Fund | Specialty & Misc | 11,800 | Added More | 1,400 | 13.46 % | $429,284 | $461,144 | $31,860 | 7.42 % | $3,780 | | | | | | History of Rydex Variable Trust-Sector Rotation Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-01 | 2009-03-31 | N-Q | Un Capital Advisers Trust-Sc Oppenheimer Main Street Small Cap Fund | Small-Cap Core | 4,200 | Added More | 1,400 | 50.00 % | $152,796 | $164,136 | $11,340 | 7.42 % | $3,780 | | | | | | History of Un Capital Advisers Trust-Sc Oppenheimer Main Street Small Cap Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-01 | 2009-03-31 | N-Q | Value Line Premier Growth Fund Inc-Value Line Premier Growth Fund Inc | Large-Cap Growth | 56,000 | No Change | 0 | 0 % | $2,037,280 | $2,188,480 | $151,200 | 7.42 % | $0 | | | | | | History of Value Line Premier Growth Fund Inc-Value Line Premier Growth Fund Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-06-01 | 2009-03-31 | N-Q | Value Line Strategic Asset Management Trust-Value Line Strategic Asset Management Trust | Multi-Cap Value | 34,000 | No Change | 0 | 0 % | $1,236,920 | $1,328,720 | $91,800 | 7.42 % | $0 | | | | | | History of Value Line Strategic Asset Management Trust-Value Line Strategic Asset Management Trust Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Alger American Fund-Alger American Growth Portfolio | Multi-Cap Growth | 27,200 | New Holding | 27,200 | 100 % | $992,800 | $1,062,976 | $70,176 | 7.06 % | $70,176 | | | | | | History of Alger American Fund-Alger American Growth Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Alger American Fund-Alger American Midcap Growth Portfolio | Mid-Cap Growth | 17,000 | New Holding | 17,000 | 100 % | $620,500 | $664,360 | $43,860 | 7.06 % | $43,860 | | | | | | History of Alger American Fund-Alger American Midcap Growth Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Alger American Fund-Alger American Small Capitalization Portfolio | Small-Cap Core | 105,700 | New Holding | 105,700 | 100 % | $3,858,050 | $4,130,756 | $272,706 | 7.06 % | $272,706 | | | | | | History of Alger American Fund-Alger American Small Capitalization Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Alger American Fund-Alger American Smallcap And Midcap Growth Portfolio | No Data | 330 | No Compare | | | $12,045 | $12,896 | $851 | 7.06 % | | | | | | | History of Alger American Fund-Alger American Smallcap And Midcap Growth Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Allianz Funds-Occ Value | Large-Cap Value | 20,545 | Sold Some | -20,385 | -49.80 % | $749,893 | $802,899 | $53,006 | 7.06 % | $-52,593 | | | | | | History of Allianz Funds-Occ Value Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Allianz Variable Insurance Products Trust-Azl Lmp Small Cap Growth Fund | Small-Cap Growth | 2,880 | No Change | 0 | 0 % | $105,120 | $112,550 | $7,430 | 7.06 % | $0 | | | | | | History of Allianz Variable Insurance Products Trust-Azl Lmp Small Cap Growth Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | American Century Variable Portfolios Inc-Vp Vista Fund | Specialty & Misc | 15,660 | Added More | 1,088 | 7.46 % | $571,590 | $611,993 | $40,403 | 7.06 % | $2,807 | | | | | | History of American Century Variable Portfolios Inc-Vp Vista Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Anchor Series Trust-Growth Portfolio | Multi-Cap Growth | 1,636 | New Holding | 1,636 | 100 % | $59,714 | $63,935 | $4,221 | 7.06 % | $4,221 | | | | | | History of Anchor Series Trust-Growth Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Calvert Variable Series Inc-Ameritas Mid Cap Growth Portfolio | Mid-Cap Growth | 4,350 | New Holding | 4,350 | 100 % | $158,775 | $169,998 | $11,223 | 7.06 % | $11,223 | | | | | | History of Calvert Variable Series Inc-Ameritas Mid Cap Growth Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Dws Investments Vit Funds-Dws Small Cap Index Vip | Small-Cap Core | 25,796 | Added More | 2,100 | 8.86 % | $941,554 | $1,008,108 | $66,554 | 7.06 % | $5,418 | | | | | | History of Dws Investments Vit Funds-Dws Small Cap Index Vip Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Dws Variable Series I-Dws Health Care Vip | Health/Biotech | 23,500 | No Change | 0 | 0 % | $857,750 | $918,380 | $60,630 | 7.06 % | $0 | | | | | | History of Dws Variable Series I-Dws Health Care Vip Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Dws Variable Series Ii-Dws Balanced Vip | Flexible Portfolio | 5,600 | Added More | 4,800 | 600.00 % | $204,400 | $218,848 | $14,448 | 7.06 % | $12,384 | | | | | | History of Dws Variable Series Ii-Dws Balanced Vip Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Dws Variable Series Ii-Dws Mid Cap Growth Vip | Mid-Cap Growth | 1,200 | No Change | 0 | 0 % | $43,800 | $46,896 | $3,096 | 7.06 % | $0 | | | | | | History of Dws Variable Series Ii-Dws Mid Cap Growth Vip Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Dws Variable Series Ii-Dws Small Cap Growth Vip | Small-Cap Growth | 18,800 | Added More | 300 | 1.62 % | $686,200 | $734,704 | $48,504 | 7.06 % | $774 | | | | | | History of Dws Variable Series Ii-Dws Small Cap Growth Vip Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Dws Variable Series Ii-Dws Turner Mid Cap Growth Vip | Mid-Cap Growth | 14,310 | Sold Some | -3,070 | -17.66 % | $522,315 | $559,235 | $36,920 | 7.06 % | $-7,921 | | | | | | History of Dws Variable Series Ii-Dws Turner Mid Cap Growth Vip Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Eq Advisors Trust-Eqalliancebernstein Common Stock Portfolio | Specialty & Misc | 32,100 | No Change | 0 | 0 % | $1,171,650 | $1,254,468 | $82,818 | 7.06 % | $0 | | | | | | History of Eq Advisors Trust-Eqalliancebernstein Common Stock Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Eq Advisors Trust-Eqalliancebernstein Small Cap Growth Portfolio | Small-Cap Growth | 206,200 | Added More | 17,300 | 9.15 % | $7,526,300 | $8,058,296 | $531,996 | 7.06 % | $44,634 | | | | | | History of Eq Advisors Trust-Eqalliancebernstein Small Cap Growth Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Eq Advisors Trust-Eqbond Index Portfolio | Specialty & Misc | 114,540 | Added More | 49,080 | 74.97 % | $4,180,710 | $4,476,223 | $295,513 | 7.06 % | $126,626 | | | | | | History of Eq Advisors Trust-Eqbond Index Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Eq Advisors Trust-Eqoppenheimer Main Street Small Cap Portfolio | Small-Cap Core | 1,580 | Added More | 350 | 28.45 % | $57,670 | $61,746 | $4,076 | 7.06 % | $903 | | | | | | History of Eq Advisors Trust-Eqoppenheimer Main Street Small Cap Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Fidelity Contrafund-Fidelity Advisor New Insights Fund | Multi-Cap Growth | | Sold All | -249,100 | -100 % | | | | 7.06 % | $-642,678 | | | | | | History of Fidelity Contrafund-Fidelity Advisor New Insights Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | 13F-HR/A | Fidelity International Ltd | Institution | | Sold All | -1,600 | -100 % | | | | 7.06 % | $-4,128 | | | | | | History of Fidelity International Ltd Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Fidelity Trend Fund-Fidelity Trend Fund | Large-Cap Core | 35,100 | Sold Some | -10,900 | -23.69 % | $1,281,150 | $1,371,708 | $90,558 | 7.06 % | $-28,122 | | | | | | History of Fidelity Trend Fund-Fidelity Trend Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | 13F-HR/A | Fmr Corp | Institution | 12,252,696 | Added More | 565,438 | 4.83 % | $447,223,404 | $478,835,360 | $31,611,956 | 7.06 % | $1,458,830 | | | | | | History of Fmr Corp Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Forward Funds-Forward Legato Fund | Small-Cap Core | 33,242 | Sold Some | -20,520 | -38.16 % | $1,213,333 | $1,299,097 | $85,764 | 7.06 % | $-52,942 | | | | | | History of Forward Funds-Forward Legato Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | John Hancock Funds Ii-Mid Cap Stock Fund | Mid-Cap Growth | | Sold All | -28,300 | -100 % | | | | 7.06 % | $-73,014 | | | | | | History of John Hancock Funds Ii-Mid Cap Stock Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | John Hancock Trust-Vista Trust | Specialty & Misc | | Sold All | -13,300 | -100 % | | | | 7.06 % | $-34,314 | | | | | | History of John Hancock Trust-Vista Trust Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Jpmorgan Insurance Trust-Jpmorgan Insurance Trust Balanced Portfolio | Flexible Portfolio | 2,335 | New Holding | 2,335 | 100 % | $85,228 | $91,252 | $6,024 | 7.06 % | $6,024 | | | | | | History of Jpmorgan Insurance Trust-Jpmorgan Insurance Trust Balanced Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Jpmorgan Insurance Trust-Jpmorgan Insurance Trust Small Cap Equity Portfolio | Small-Cap Core | 425 | New Holding | 425 | 100 % | $15,513 | $16,609 | $1,097 | 7.06 % | $1,097 | | | | | | History of Jpmorgan Insurance Trust-Jpmorgan Insurance Trust Small Cap Equity Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Jpmorgan Trust I-Jpmorgan Asia Equity Fund | Specialty & Misc | 18 | New Holding | 18 | 100 % | $657 | $703 | $46 | 7.06 % | $46 | | | | | | History of Jpmorgan Trust I-Jpmorgan Asia Equity Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Jpmorgan Trust I-Jpmorgan Disciplined Equity Fund | Specialty & Misc | 9 | New Holding | 9 | 100 % | $329 | $352 | $23 | 7.06 % | $23 | | | | | | History of Jpmorgan Trust I-Jpmorgan Disciplined Equity Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Jpmorgan Trust I-Jpmorgan Diversified Fund | Flexible Portfolio | 3 | No Change | 0 | 0 % | $110 | $117 | $8 | 7.06 % | $0 | | | | | | History of Jpmorgan Trust I-Jpmorgan Diversified Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Jpmorgan Trust I-Jpmorgan Japan Fund | Japanese | 52 | New Holding | 52 | 100 % | $1,898 | $2,032 | $134 | 7.06 % | $134 | | | | | | History of Jpmorgan Trust I-Jpmorgan Japan Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Jpmorgan Trust I-Jpmorgan Small Cap Core Fund | Small-Cap Core | 61 | New Holding | 61 | 100 % | $2,227 | $2,384 | $157 | 7.06 % | $157 | | | | | | History of Jpmorgan Trust I-Jpmorgan Small Cap Core Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Lord Abbett Series Fund Inc-Growth Opportunities Portfolio | Multi-Cap Growth | 15,573 | Sold Some | -8,853 | -36.24 % | $568,415 | $608,593 | $40,178 | 7.06 % | $-22,841 | | | | | | History of Lord Abbett Series Fund Inc-Growth Opportunities Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Maxim Series Fund Inc-Maxim Small-Cap Growth Portfolio | No Data | 62,600 | Added More | 23,800 | 61.34 % | $2,284,900 | $2,446,408 | $161,508 | 7.06 % | $61,404 | | | | | | History of Maxim Series Fund Inc-Maxim Small-Cap Growth Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Maxim Series Fund Inc-Maxim Small-Cap Growth Portfolio | No Data | 62,600 | Added More | 34,700 | 124.37 % | $2,284,900 | $2,446,408 | $161,508 | 7.06 % | $89,526 | | | | | | History of Maxim Series Fund Inc-Maxim Small-Cap Growth Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Oberweis Funds-Oberweis China Opportunities Fund | China Region | 1,100 | New Holding | 1,100 | 100 % | $40,150 | $42,988 | $2,838 | 7.06 % | $2,838 | | | | | | History of Oberweis Funds-Oberweis China Opportunities Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Oppenheimer Variable Account Funds-Oppenheimer Main Street Fundva | Specialty & Misc | | Sold All | -11,900 | -100 % | | | | 7.06 % | $-30,702 | | | | | | History of Oppenheimer Variable Account Funds-Oppenheimer Main Street Fundva Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Phoenix Edge Series Fund-Phoenix Capital Growth | Large-Cap Growth | 19,900 | New Holding | 19,900 | 100 % | $726,350 | $777,692 | $51,342 | 7.06 % | $51,342 | | | | | | History of Phoenix Edge Series Fund-Phoenix Capital Growth Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Pioneer Research Fund-Pioneer Research Fund | Large-Cap Core | 14,000 | New Holding | 14,000 | 100 % | $511,000 | $547,120 | $36,120 | 7.06 % | $36,120 | | | | | | History of Pioneer Research Fund-Pioneer Research Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Pioneer Series Trust Ii-Pioneer Growth Opportunities Fund | Multi-Cap Growth | 42,100 | New Holding | 42,100 | 100 % | $1,536,650 | $1,645,268 | $108,618 | 7.06 % | $108,618 | | | | | | History of Pioneer Series Trust Ii-Pioneer Growth Opportunities Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Pioneer Variable Contracts Trust Ma-Pioneer Growth Opportunities Vct Portfolio | Multi-Cap Growth | 20,300 | New Holding | 20,300 | 100 % | $740,950 | $793,324 | $52,374 | 7.06 % | $52,374 | | | | | | History of Pioneer Variable Contracts Trust Ma-Pioneer Growth Opportunities Vct Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Profunds-Bull Profund | Large-Cap Core | 1,064 | Sold Some | -5,684 | -84.23 % | $38,836 | $41,581 | $2,745 | 7.06 % | $-14,665 | | | | | | History of Profunds-Bull Profund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Profunds-Profund Vp Health Care | Health/Biotech | | Sold All | -3,320 | -100 % | | | | 7.06 % | $-8,566 | | | | | | History of Profunds-Profund Vp Health Care Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Putnam Variable Trust-Putnam Vt Vista Fund | Specialty & Misc | 42,500 | New Holding | 42,500 | 100 % | $1,551,250 | $1,660,900 | $109,650 | 7.06 % | $109,650 | | | | | | History of Putnam Variable Trust-Putnam Vt Vista Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Treettracks Series Trust-Spdr Dividend Etf | Specialty & Misc | 500,641 | New Holding | 500,641 | 100 % | $18,273,397 | $19,565,050 | $1,291,654 | 7.06 % | $1,291,654 | | | | | | History of Treettracks Series Trust-Spdr Dividend Etf Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Vanguard Variable Insurance Funds-Balanced Portfolio | Flexible Portfolio | | Sold All | -26,773 | -100 % | | | | 7.06 % | $-69,074 | | | | | | History of Vanguard Variable Insurance Funds-Balanced Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Variable Insurance Products Fund Ii-Contrafund Portfolio | Specialty & Misc | 27,700 | New Holding | 27,700 | 100 % | $1,011,050 | $1,082,516 | $71,466 | 7.06 % | $71,466 | | | | | | History of Variable Insurance Products Fund Ii-Contrafund Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Variable Insurance Products Fund Ii-Disciplined Small Cap Portfolio | Small-Cap Core | 1,110 | Added More | 432 | 63.71 % | $40,515 | $43,379 | $2,864 | 7.06 % | $1,115 | | | | | | History of Variable Insurance Products Fund Ii-Disciplined Small Cap Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Variable Insurance Products Fund Iv-Consumer Discretionary Portfolio | Specialty & Misc | | Sold All | -1,000 | -100 % | | | | 7.06 % | $-2,580 | | | | | | History of Variable Insurance Products Fund Iv-Consumer Discretionary Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Variable Insurance Products Fund Iv-Growth Stock Portfolio | Multi-Cap Growth | 600 | Sold Some | -1,500 | -71.42 % | $21,900 | $23,448 | $1,548 | 7.06 % | $-3,870 | | | | | | History of Variable Insurance Products Fund Iv-Growth Stock Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Variable Insurance Products Fund Iv-Health Care Portfolio | Health/Biotech | 11,900 | Added More | 7,000 | 142.85 % | $434,350 | $465,052 | $30,702 | 7.06 % | $18,060 | | | | | | History of Variable Insurance Products Fund Iv-Health Care Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Variable Insurance Products Iii-Growth Opportunities Portfolio | Multi-Cap Growth | 21,300 | New Holding | 21,300 | 100 % | $777,450 | $832,404 | $54,954 | 7.06 % | $54,954 | | | | | | History of Variable Insurance Products Iii-Growth Opportunities Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Wilshire Mutual Funds Inc-Dow Jones Wilshire 5000 Index Portfolio | Multi-Cap Core | | Sold All | -4,500 | -100 % | | | | 7.06 % | $-11,610 | | | | | | History of Wilshire Mutual Funds Inc-Dow Jones Wilshire 5000 Index Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-29 | 2009-03-31 | N-Q | Wilshire Mutual Funds Inc-Wilshire Small Company Growth Portfolio | Small-Cap Growth | 1,050 | No Change | 0 | 0 % | $38,325 | $41,034 | $2,709 | 7.06 % | $0 | | | | | | History of Wilshire Mutual Funds Inc-Wilshire Small Company Growth Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-28 | 2009-03-31 | 13F-HR/A | Bank Of America Corp | Institution | | Sold All | -583,548 | -100 % | | | | 9.22 % | $-1,925,708 | | | | | | History of Bank Of America Corp Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-28 | 2009-03-31 | 13F-HR/A | Clearbridge Advisors Llc | Institution | 413,036 | Sold Some | -94,005 | -18.53 % | $14,778,428 | $16,141,447 | $1,363,019 | 9.22 % | $-310,217 | | | | | | History of Clearbridge Advisors Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-28 | 2009-03-31 | N-Q | Dreyfus Founders Funds Inc-Dreyfus Founders Discovery Fund | Small-Cap Growth | 41,780 | Added More | 240 | 0.57 % | $1,494,888 | $1,632,762 | $137,874 | 9.22 % | $792 | | | | | | History of Dreyfus Founders Funds Inc-Dreyfus Founders Discovery Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-28 | 2009-03-31 | N-Q | Dreyfus Founders Funds Inc-Dreyfus Founders Growth Fund | Large-Cap Growth | 97,033 | New Holding | 97,033 | 100 % | $3,471,841 | $3,792,050 | $320,209 | 9.22 % | $320,209 | | | | | | History of Dreyfus Founders Funds Inc-Dreyfus Founders Growth Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-28 | 2009-03-31 | N-Q | Dreyfus Variable Investment Fund-Developing Leaders Portfolio | Specialty & Misc | | Sold All | -325,000 | -100 % | | | | 9.22 % | $-1,072,500 | | | | | | History of Dreyfus Variable Investment Fund-Developing Leaders Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-28 | 2009-03-31 | N-Q | Dreyfus Variable Investment Fund-Growth And Income Portfolio | Multi-Cap Growth | 5,500 | New Holding | 5,500 | 100 % | $196,790 | $214,940 | $18,150 | 9.22 % | $18,150 | | | | | | History of Dreyfus Variable Investment Fund-Growth And Income Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-28 | 2009-03-31 | N-Q | Evergreen Variable Annuity Trust De-Evergreen Va Growth Fund | Multi-Cap Growth | 10,800 | Sold Some | -5,000 | -31.64 % | $386,424 | $422,064 | $35,640 | 9.22 % | $-16,500 | | | | | | History of Evergreen Variable Annuity Trust De-Evergreen Va Growth Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-28 | 2009-03-31 | N-CSRS | Fidelity Central Investment Portfolios Llc-Fidelity Health Care | Health/Biotech | 116,318 | New Holding | 116,318 | 100 % | $4,161,858 | $4,545,707 | $383,849 | 9.22 % | $383,849 | | | | | | History of Fidelity Central Investment Portfolios Llc-Fidelity Health Care Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-28 | 2009-03-31 | N-CSRS | Fidelity Central Investment Portfolios Llc-Fidelity Utilitie | Utility | | Sold All | -45,800 | -100 % | | | | 9.22 % | $-151,140 | | | | | | History of Fidelity Central Investment Portfolios Llc-Fidelity Utilitie Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-28 | 2009-03-31 | N-Q | Jp Morgan Series Trust Ii-Jpmorgan Small Company Portfolio | Small-Cap Core | 8,300 | New Holding | 8,300 | 100 % | $296,974 | $324,364 | $27,390 | 9.22 % | $27,390 | | | | | | History of Jp Morgan Series Trust Ii-Jpmorgan Small Company Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-28 | 2009-03-31 | N-Q | Legg Mason Partners Equity Trust-Legg Mason Partners Small Cap Growth Fund | Small-Cap Growth | | Sold All | -437,200 | -100 % | | | | 9.22 % | $-1,442,760 | | | | | | History of Legg Mason Partners Equity Trust-Legg Mason Partners Small Cap Growth Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-28 | 2009-03-31 | N-Q | Legg Mason Partners Variable Equity Trust-Legg Mason Partners Variable Small Cap Growth Portfolio | Small-Cap Growth | | Sold All | -68,040 | -100 % | | | | 9.22 % | $-224,532 | | | | | | History of Legg Mason Partners Variable Equity Trust-Legg Mason Partners Variable Small Cap Growth Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-28 | 2009-03-31 | N-Q | Masters Select Funds Trust-The Masters Select Smaller Companies Fund | Small-Cap Core | 32,419 | No Change | 0 | 0 % | $1,159,952 | $1,266,935 | $106,983 | 9.22 % | $0 | | | | | | History of Masters Select Funds Trust-The Masters Select Smaller Companies Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-28 | 2009-03-31 | 13F-HR/A | Merrill Lynch And Co Inc | Institution | | Sold All | -15,661 | -100 % | | | | 9.22 % | $-51,681 | | | | | | History of Merrill Lynch And Co Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-28 | 2009-03-31 | N-Q | Mma Praxis Mutual Funds-Mma Praxis Growth Index Fund | Large-Cap Growth | 383 | No Change | 0 | 0 % | $13,704 | $14,968 | $1,264 | 9.22 % | $0 | | | | | | History of Mma Praxis Mutual Funds-Mma Praxis Growth Index Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-28 | 2009-03-31 | 13F-HR | Northern Trust Co Of Connecticut | Institution | 63,301 | Added More | 1,392 | 2.24 % | $2,264,910 | $2,473,803 | $208,893 | 9.22 % | $4,594 | | | | | | History of Northern Trust Co Of Connecticut Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-28 | 2009-03-31 | 13F-HR/A | Oppenheimer Funds Inc | Institution | 893,705 | Added More | 59,105 | 7.08 % | $31,976,765 | $34,925,991 | $2,949,227 | 9.22 % | $195,047 | | | | | | History of Oppenheimer Funds Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-28 | 2009-03-31 | N-Q | Pacific Select Fund-Pacific Select Fund | Pacific Region | 5,300 | Added More | 100 | 1.92 % | $189,634 | $207,124 | $17,490 | 9.22 % | $330 | | | | | | History of Pacific Select Fund-Pacific Select Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-28 | 2009-03-31 | N-Q | Rs Investment Trust-Rs Emerging Growth Fund | Emerging Markets | | Sold All | -56,690 | -100 % | | | | 9.22 % | $-187,077 | | | | | | History of Rs Investment Trust-Rs Emerging Growth Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-28 | 2009-03-31 | N-Q | Rs Investment Trust-Rs Smaller Company Growth Fund | Small-Cap Growth | | Sold All | -28,380 | -100 % | | | | 9.22 % | $-93,654 | | | | | | History of Rs Investment Trust-Rs Smaller Company Growth Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-28 | 2009-03-31 | N-Q | Vanguard Balanced Index Funds-Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | | Sold All | -34,092 | -100 % | | | | 9.22 % | $-112,504 | | | | | | History of Vanguard Balanced Index Funds-Vanguard Balanced Index Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-28 | 2009-03-31 | N-Q | Vanguard Index Funds-Vanguard Extended Market Index Fund | Mid-Cap Core | | Sold All | -425,465 | -100 % | | | | 9.22 % | $-1,404,035 | | | | | | History of Vanguard Index Funds-Vanguard Extended Market Index Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-28 | 2009-03-31 | N-Q | Vanguard Index Funds-Vanguard Total Stock Market Index Fund | Multi-Cap Core | | Sold All | -618,074 | -100 % | | | | 9.22 % | $-2,039,644 | | | | | | History of Vanguard Index Funds-Vanguard Total Stock Market Index Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-27 | 2009-03-31 | N-Q | Advisors Series Trust-Capital Advisors Growth Fund | Multi-Cap Growth | | Sold All | -4,500 | -100 % | | | | 9.59 % | $-15,390 | | | | | | History of Advisors Series Trust-Capital Advisors Growth Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-27 | 2009-03-31 | N-Q | Eligman Capital Fund Inc-Seligman Capital Fund Inc | Mid-Cap Growth | 24,100 | No Change | 0 | 0 % | $859,406 | $941,828 | $82,422 | 9.59 % | $0 | | | | | | History of Eligman Capital Fund Inc-Seligman Capital Fund Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-27 | 2009-03-31 | N-Q | Eligman Portfolios Incny-Seligman Capital Portfolio | Specialty & Misc | 700 | No Change | 0 | 0 % | $24,962 | $27,356 | $2,394 | 9.59 % | $0 | | | | | | History of Eligman Portfolios Incny-Seligman Capital Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-27 | 2009-03-31 | N-Q | Jpmorgan Trust Ii-Jpmorgan Technology Fund | Science & Tech | | Sold All | -7 | -100 % | | | | 9.59 % | $-24 | | | | | | History of Jpmorgan Trust Ii-Jpmorgan Technology Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-27 | 2009-03-31 | N-Q | Mml Series Investment Fund Ii-Mml Small Cap Equity Fund | Small-Cap Core | 2,260 | New Holding | 2,260 | 100 % | $80,592 | $88,321 | $7,729 | 9.59 % | $7,729 | | | | | | History of Mml Series Investment Fund Ii-Mml Small Cap Equity Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-27 | 2009-03-31 | N-Q | Mml Series Investment Fund-Mml Emerging Growth Fund | Emerging Markets | 4,100 | New Holding | 4,100 | 100 % | $146,206 | $160,228 | $14,022 | 9.59 % | $14,022 | | | | | | History of Mml Series Investment Fund-Mml Emerging Growth Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-27 | 2009-03-31 | N-Q | Mml Series Investment Fund-Mml Mid Cap Growth Fund | Mid-Cap Growth | 24,600 | New Holding | 24,600 | 100 % | $877,236 | $961,368 | $84,132 | 9.59 % | $84,132 | | | | | | History of Mml Series Investment Fund-Mml Mid Cap Growth Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-27 | 2009-03-31 | N-CSRS | Oppenheimer Discovery Fund-Oppenheimer Discovery Fund | Small-Cap Growth | 222,600 | New Holding | 222,600 | 100 % | $7,937,916 | $8,699,208 | $761,292 | 9.59 % | $761,292 | | | | | | History of Oppenheimer Discovery Fund-Oppenheimer Discovery Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-27 | 2009-03-31 | N-Q | Oppenheimer Main Street Small Cap Fund-Oppenheimer Main Street Small Cap Fund | Small-Cap Core | | Sold All | -69,300 | -100 % | | | | 9.59 % | $-237,006 | | | | | | History of Oppenheimer Main Street Small Cap Fund-Oppenheimer Main Street Small Cap Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-26 | 2009-03-31 | N-Q | Columbia Acorn Trust-Columbia Acorn Usa | Specialty & Misc | 235,000 | Sold Some | -235,000 | -50.00 % | $8,394,200 | $9,183,800 | $789,600 | 9.40 % | $-789,600 | | | | | | History of Columbia Acorn Trust-Columbia Acorn Usa Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-26 | 2009-03-31 | N-Q | Ge Investment Funds Inc-Money Market Fund | Specialty & Misc | 1,200 | New Holding | 1,200 | 100 % | $42,864 | $46,896 | $4,032 | 9.40 % | $4,032 | | | | | | History of Ge Investment Funds Inc-Money Market Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-26 | 2009-03-31 | N-Q | Jnl Variable Fund Llc-Jnlmcm Healthcare Sector Fund | Health/Biotech | 8 | No Change | 0 | 0 % | $286 | $313 | $27 | 9.40 % | $0 | | | | | | History of Jnl Variable Fund Llc-Jnlmcm Healthcare Sector Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-26 | 2009-03-31 | N-Q | Ohio National Fund Inc-Bryton Growth Portfolio | Multi-Cap Growth | 14,000 | New Holding | 14,000 | 100 % | $500,080 | $547,120 | $47,040 | 9.40 % | $47,040 | | | | | | History of Ohio National Fund Inc-Bryton Growth Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-26 | 2009-03-31 | N-Q | Ohio National Fund Inc-Millennium Portfolio | Mid-Cap Growth | 9,700 | New Holding | 9,700 | 100 % | $346,484 | $379,076 | $32,592 | 9.40 % | $32,592 | | | | | | History of Ohio National Fund Inc-Millennium Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-26 | 2009-03-31 | 13F-HR | Qa3 Financial Llc | No Data | 6 | No Change | 0 | 0 % | $214 | $234 | $20 | 9.40 % | $0 | | | | | | History of Qa3 Financial Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-26 | 2009-03-31 | 13F-HR/A | Royal Bank Of Canada Investment Management Uk Ltd | Institution | 6,365 | Sold Some | -1,036 | -13.99 % | $227,358 | $248,744 | $21,386 | 9.40 % | $-3,481 | | | | | | History of Royal Bank Of Canada Investment Management Uk Ltd Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-26 | 2009-03-31 | 13F-HR/A | Td Asset Management Inc | Institution | 162,200 | Sold Some | -11,100 | -6.40 % | $5,793,784 | $6,338,776 | $544,992 | 9.40 % | $-37,296 | | | | | | History of Td Asset Management Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-26 | 2009-03-31 | N-Q | Tiaa Cref Life Fund-Social Choice Equity Fund | Multi-Cap Core | | Sold All | -200 | -100 % | | | | 9.40 % | $-672 | | | | | | History of Tiaa Cref Life Fund-Social Choice Equity Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-26 | 2009-03-31 | N-Q | Tiaa Cref Life Fund-Stock Index Fund | Specialty & Misc | 1,066 | Added More | 190 | 21.68 % | $38,078 | $41,659 | $3,582 | 9.40 % | $638 | | | | | | History of Tiaa Cref Life Fund-Stock Index Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-26 | 2009-03-31 | N-Q | Wells Fargo Variable Trust-Vt Discovery Fund | Specialty & Misc | 21,300 | New Holding | 21,300 | 100 % | $760,836 | $832,404 | $71,568 | 9.40 % | $71,568 | | | | | | History of Wells Fargo Variable Trust-Vt Discovery Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-21 | 2009-03-31 | 13F-HR/A | Allianz Global Investors Of America L P | Institution | 125,113 | Sold Some | -7,018 | -5.31 % | $4,136,236 | $4,889,416 | $753,180 | 18.20 % | $-42,248 | | | | | | History of Allianz Global Investors Of America L P Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-20 | 2009-03-31 | 13F-HR/A | Visium Asset Management Llc | Institution | 200,000 | Added More | 190,000 | 1900.00 % | $6,584,000 | $7,816,000 | $1,232,000 | 18.71 % | $1,170,400 | | | | | | History of Visium Asset Management Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-19 | 2009-03-31 | 13F-HR/A | Zebra Capital Management Llc | Institution | 100 | Sold Some | -154 | -60.62 % | $3,290 | $3,908 | $618 | 18.78 % | $-952 | | | | | | History of Zebra Capital Management Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-18 | 2009-03-31 | 13F-HR/A | Ashfield Capital Partners Llc | Institution | 1,635 | New Holding | 1,635 | 100 % | $54,478 | $63,896 | $9,418 | 17.28 % | $9,418 | | | | | | History of Ashfield Capital Partners Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-18 | 2009-03-31 | 13F-HR | Davidson D A And Co | Institution | 6,161 | Sold Some | -6,158 | -49.98 % | $205,285 | $240,772 | $35,487 | 17.28 % | $-35,470 | | | | | | History of Davidson D A And Co Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-18 | 2009-03-31 | 13F-HR/A | Diamondback Capital Management Llc | Institution | 126,900 | Added More | 84,647 | 200.33 % | $4,228,308 | $4,959,252 | $730,944 | 17.28 % | $487,567 | | | | | | History of Diamondback Capital Management Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-18 | 2009-03-31 | 13F-HR/A | Highbridge Capital Management Llc | Institution | 270,814 | Added More | 216,147 | 395.38 % | $9,023,522 | $10,583,411 | $1,559,889 | 17.28 % | $1,245,007 | | | | | | History of Highbridge Capital Management Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-18 | 2009-03-31 | N-Q | Mutual Of America Institutional Funds Inc-Bond Fund | Specialty & Misc | 1,024 | Added More | 150 | 17.16 % | $34,120 | $40,018 | $5,898 | 17.28 % | $864 | | | | | | History of Mutual Of America Institutional Funds Inc-Bond Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-18 | 2009-03-31 | N-Q | Mutual Of America Investment Corp-Bond Fund | Specialty & Misc | 56,312 | Added More | 7,250 | 14.77 % | $1,876,316 | $2,200,673 | $324,357 | 17.28 % | $41,760 | | | | | | History of Mutual Of America Investment Corp-Bond Fund Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-18 | 2009-03-31 | 13F-HR | Value Line Inc | Institution | 238,700 | Added More | 21,200 | 9.74 % | $7,953,484 | $9,328,396 | $1,374,912 | 17.28 % | $122,112 | | | | | | History of Value Line Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-18 | 2008-12-31 | 13F-HR/A | Value Line Inc | Institution | 217,500 | Sold Some | -21,200 | -8.88 % | $7,247,100 | $8,499,900 | $1,252,800 | 17.28 % | $-122,112 | | | | | | History of Value Line Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-18 | 2008-09-30 | 13F-HR/A | Value Line Inc | Institution | 238,700 | Added More | 119,600 | 100.41 % | $7,953,484 | $9,328,396 | $1,374,912 | 17.28 % | $688,896 | | | | | | History of Value Line Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-05-15 | 13F-HR | Credit Suisse | Institution | | Sold All | -44,143 | -100 % | | | | 15.96 % | $-237,489 | | | | | | History of Credit Suisse Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | 1798 Global Partners Ltd | Institution | 30,000 | New Holding | 30,000 | 100 % | $1,011,000 | $1,172,400 | $161,400 | 15.96 % | $161,400 | | | | | | History of 1798 Global Partners Ltd Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Alger Fred Management Inc | Institution | 1,757,608 | Sold Some | -594,379 | -25.27 % | $59,231,390 | $68,687,321 | $9,455,931 | 15.96 % | $-3,197,759 | | | | | | History of Alger Fred Management Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Aqr Capital Management Llc | Institution | 16,900 | New Holding | 16,900 | 100 % | $569,530 | $660,452 | $90,922 | 15.96 % | $90,922 | | | | | | History of Aqr Capital Management Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Ashfield And Co Inc | Institution | 1,635 | New Holding | 1,635 | 100 % | $55,100 | $63,896 | $8,796 | 15.96 % | $8,796 | | | | | | History of Ashfield And Co Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Axa | Institution | 3,178,327 | Sold Some | -299,181 | -8.60 % | $107,109,620 | $124,209,019 | $17,099,399 | 15.96 % | $-1,609,594 | | | | | | History of Axa Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Bartlett And Co | Institution | 1,200 | No Change | 0 | 0 % | $40,440 | $46,896 | $6,456 | 15.96 % | $0 | | | | | | History of Bartlett And Co Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Batterymarch Financial Management Inc | Institution | 27,052 | Sold Some | -113,478 | -80.75 % | $911,652 | $1,057,192 | $145,540 | 15.96 % | $-610,512 | | | | | | History of Batterymarch Financial Management Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Blair William And Co | Institution | 78,965 | New Holding | 78,965 | 100 % | $2,661,121 | $3,085,952 | $424,832 | 15.96 % | $424,832 | | | | | | History of Blair William And Co Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Bridgewater Investment Management Llc | Institution | 85 | New Holding | 85 | 100 % | $2,865 | $3,322 | $457 | 15.96 % | $457 | | | | | | History of Bridgewater Investment Management Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Bridgeway Capital Management Inc | Institution | 39,400 | No Change | 0 | 0 % | $1,327,780 | $1,539,752 | $211,972 | 15.96 % | $0 | | | | | | History of Bridgeway Capital Management Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Caisse De Depot Et Placement Du Quebec | Institution | | Sold All | -5,697 | -100 % | | | | 15.96 % | $-30,650 | | | | | | History of Caisse De Depot Et Placement Du Quebec Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Capital One Financial Corp | Institution | 140 | New Holding | 140 | 100 % | $4,718 | $5,471 | $753 | 15.96 % | $753 | | | | | | History of Capital One Financial Corp Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Capital World Investor | Institution | 300,000 | No Change | 0 | 0 % | $10,110,000 | $11,724,000 | $1,614,000 | 15.96 % | $0 | | | | | | History of Capital World Investor Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Citadel L P | Institution | 202,857 | New Holding | 202,857 | 100 % | $6,836,281 | $7,927,652 | $1,091,371 | 15.96 % | $1,091,371 | | | | | | History of Citadel L P Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Citigroup Inc | Institution | 176,809 | Sold Some | -130,935 | -42.54 % | $5,958,463 | $6,909,696 | $951,232 | 15.96 % | $-704,430 | | | | | | History of Citigroup Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Driehaus Capital Management Llc | Institution | 383,608 | Added More | 105,108 | 37.74 % | $12,927,590 | $14,991,401 | $2,063,811 | 15.96 % | $565,481 | | | | | | History of Driehaus Capital Management Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Expo Capital Management Llc | Institution | 135,000 | New Holding | 135,000 | 100 % | $4,549,500 | $5,275,800 | $726,300 | 15.96 % | $726,300 | | | | | | History of Expo Capital Management Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Fifth Third Asset Management Inc | Institution | 204,190 | Sold Some | -11,690 | -5.41 % | $6,881,203 | $7,979,745 | $1,098,542 | 15.96 % | $-62,892 | | | | | | History of Fifth Third Asset Management Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Fifth Third Bancorp | Institution | 51,552 | Added More | 4,880 | 10.45 % | $1,737,302 | $2,014,652 | $277,350 | 15.96 % | $26,254 | | | | | | History of Fifth Third Bancorp Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Fifth Third Securitie | Institution | 970 | Sold Some | -487 | -33.42 % | $32,689 | $37,908 | $5,219 | 15.96 % | $-2,620 | | | | | | History of Fifth Third Securitie Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Fort Washington Investment Advisors Inc | Institution | 254,775 | New Holding | 254,775 | 100 % | $8,585,918 | $9,956,607 | $1,370,690 | 15.96 % | $1,370,690 | | | | | | History of Fort Washington Investment Advisors Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Galleon Management L P | Institution | 20,000 | New Holding | 20,000 | 100 % | $674,000 | $781,600 | $107,600 | 15.96 % | $107,600 | | | | | | History of Galleon Management L P Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Gartmore Mutual Fund Capital Trust | Institution | 134,716 | Added More | 38,861 | 40.54 % | $4,539,929 | $5,264,701 | $724,772 | 15.96 % | $209,072 | | | | | | History of Gartmore Mutual Fund Capital Trust Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | General Re New England Asset Management Inc | Institution | 870 | New Holding | 870 | 100 % | $29,319 | $34,000 | $4,681 | 15.96 % | $4,681 | | | | | | History of General Re New England Asset Management Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Geode Capital Management Llc | Institution | 165,091 | Added More | 13,392 | 8.82 % | $5,563,567 | $6,451,756 | $888,190 | 15.96 % | $72,049 | | | | | | History of Geode Capital Management Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Hambrecht And Quist Capital Management Llc | Institution | 300,800 | Added More | 23,100 | 8.31 % | $10,136,960 | $11,755,264 | $1,618,304 | 15.96 % | $124,278 | | | | | | History of Hambrecht And Quist Capital Management Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Harris Financial Corp | Institution | 24,870 | Added More | 1,600 | 6.87 % | $838,119 | $971,920 | $133,801 | 15.96 % | $8,608 | | | | | | History of Harris Financial Corp Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Haw D E And Co Inc | Institution | 112,493 | Sold Some | -196,293 | -63.56 % | $3,791,014 | $4,396,226 | $605,212 | 15.96 % | $-1,056,056 | | | | | | History of Haw D E And Co Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Igma Capital Management Llc | Institution | 185,000 | Added More | 53,000 | 40.15 % | $6,234,500 | $7,229,800 | $995,300 | 15.96 % | $285,140 | | | | | | History of Igma Capital Management Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Janus Capital Management Llc | Institution | 1,014,219 | Added More | 137,035 | 15.62 % | $34,179,180 | $39,635,679 | $5,456,498 | 15.96 % | $737,248 | | | | | | History of Janus Capital Management Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Jennison Associates Llc | Institution | 471,000 | Sold Some | -107,800 | -18.62 % | $15,872,700 | $18,406,680 | $2,533,980 | 15.96 % | $-579,964 | | | | | | History of Jennison Associates Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Leuthold Weeden Capital Management Llc | Institution | 421,435 | Sold Some | -8,784 | -2.04 % | $14,202,360 | $16,469,680 | $2,267,320 | 15.96 % | $-47,258 | | | | | | History of Leuthold Weeden Capital Management Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Loomis Sayles And Co L P | Institution | 124,756 | Added More | 12,652 | 11.28 % | $4,204,277 | $4,875,464 | $671,187 | 15.96 % | $68,068 | | | | | | History of Loomis Sayles And Co L P Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Lord Abbett And Co Llc | Institution | 551,727 | Sold Some | -155,708 | -22.01 % | $18,593,200 | $21,561,491 | $2,968,291 | 15.96 % | $-837,709 | | | | | | History of Lord Abbett And Co Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | N-Q | Met Investors Series Trust-Lazard Mid Cap Portfolio | Mid-Cap Core | 89,000 | No Change | 0 | 0 % | $2,999,300 | $3,478,120 | $478,820 | 15.96 % | $0 | | | | | | History of Met Investors Series Trust-Lazard Mid Cap Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | N-Q | Met Investors Series Trust-Turner Mid Cap Growth Portfolio | Mid-Cap Growth | 96,890 | Sold Some | -4,590 | -4.52 % | $3,265,193 | $3,786,461 | $521,268 | 15.96 % | $-24,694 | | | | | | History of Met Investors Series Trust-Turner Mid Cap Growth Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Millennium Management Llc | Institution | 152,300 | Sold Some | -556,254 | -78.50 % | $5,132,510 | $5,951,884 | $819,374 | 15.96 % | $-2,992,647 | | | | | | History of Millennium Management Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Morgan Stanley | Institution | 1,140,324 | Sold Some | -67,916 | -5.62 % | $38,428,919 | $44,563,862 | $6,134,943 | 15.96 % | $-365,388 | | | | | | History of Morgan Stanley Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Nomura Asset Management Co Ltd | Institution | 137,800 | Added More | 26,000 | 23.25 % | $4,643,860 | $5,385,224 | $741,364 | 15.96 % | $139,880 | | | | | | History of Nomura Asset Management Co Ltd Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Northern Trust Corp | Institution | 782,171 | Added More | 89,243 | 12.87 % | $26,359,163 | $30,567,243 | $4,208,080 | 15.96 % | $480,127 | | | | | | History of Northern Trust Corp Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Northwestern Mutual Wealth Management Co | Institution | 2,610 | Sold Some | -421 | -13.88 % | $87,957 | $101,999 | $14,042 | 15.96 % | $-2,265 | | | | | | History of Northwestern Mutual Wealth Management Co Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Oberweis Asset Management Inc | Institution | 21,430 | Sold Some | -10,280 | -32.41 % | $722,191 | $837,484 | $115,293 | 15.96 % | $-55,306 | | | | | | History of Oberweis Asset Management Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Old Mutual Asset Managers Uk Ltd | Institution | 16,800 | New Holding | 16,800 | 100 % | $566,160 | $656,544 | $90,384 | 15.96 % | $90,384 | | | | | | History of Old Mutual Asset Managers Uk Ltd Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Onar Capital Management Llc | Institution | 43,000 | New Holding | 43,000 | 100 % | $1,449,100 | $1,680,440 | $231,340 | 15.96 % | $231,340 | | | | | | History of Onar Capital Management Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Orbimed Advisors Llc | Institution | 1,128,500 | Added More | 1,012,900 | 876.21 % | $38,030,450 | $44,101,780 | $6,071,330 | 15.96 % | $5,449,402 | | | | | | History of Orbimed Advisors Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Partner Fund Management Lp | Institution | 259,987 | Added More | 177,126 | 213.76 % | $8,761,562 | $10,160,292 | $1,398,730 | 15.96 % | $952,938 | | | | | | History of Partner Fund Management Lp Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Partner Investment Management Lp | Institution | 165,300 | Added More | 113,854 | 221.30 % | $5,570,610 | $6,459,924 | $889,314 | 15.96 % | $612,535 | | | | | | History of Partner Investment Management Lp Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Pequot Capital Management Inc | Institution | 409,200 | No Change | 0 | 0 % | $13,790,040 | $15,991,536 | $2,201,496 | 15.96 % | $0 | | | | | | History of Pequot Capital Management Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Perimeter Capital Partners Llc | Institution | 178,642 | Added More | 13,520 | 8.18 % | $6,020,235 | $6,981,329 | $961,094 | 15.96 % | $72,738 | | | | | | History of Perimeter Capital Partners Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Polar Capital Llp | Institution | 53,800 | No Change | 0 | 0 % | $1,813,060 | $2,102,504 | $289,444 | 15.96 % | $0 | | | | | | History of Polar Capital Llp Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Principled Asset Administration Llc | Institution | 248,600 | Sold Some | -296,700 | -54.41 % | $8,377,820 | $9,715,288 | $1,337,468 | 15.96 % | $-1,596,246 | | | | | | History of Principled Asset Administration Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Rafferty Asset Management Llc | Institution | 26,612 | Added More | 10,897 | 69.34 % | $896,824 | $1,039,997 | $143,173 | 15.96 % | $58,626 | | | | | | History of Rafferty Asset Management Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Rainier Investment Management Inc | Institution | 401,825 | New Holding | 401,825 | 100 % | $13,541,503 | $15,703,321 | $2,161,819 | 15.96 % | $2,161,819 | | | | | | History of Rainier Investment Management Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR/A | Redwood Investments Llc | Institution | 62,830 | Sold Some | -18,850 | -23.07 % | $2,117,371 | $2,455,396 | $338,025 | 15.96 % | $-101,413 | | | | | | History of Redwood Investments Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Russell Frank Co | Institution | 619,605 | Added More | 155,353 | 33.46 % | $20,880,689 | $24,214,163 | $3,333,475 | 15.96 % | $835,799 | | | | | | History of Russell Frank Co Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Sac Capital Advisors Lp | No Data | 300,000 | No Compare | | | $10,110,000 | $11,724,000 | $1,614,000 | 15.96 % | | | | | | | History of Sac Capital Advisors Lp Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Thales Fund Management Llc | Institution | 800 | New Holding | 800 | 100 % | $26,960 | $31,264 | $4,304 | 15.96 % | $4,304 | | | | | | History of Thales Fund Management Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Tryphon Capital Advisers Inc | Institution | 146,915 | New Holding | 146,915 | 100 % | $4,951,036 | $5,741,438 | $790,403 | 15.96 % | $790,403 | | | | | | History of Tryphon Capital Advisers Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Two Sigma Investments Llc | Institution | 187,557 | Added More | 150,999 | 413.03 % | $6,320,671 | $7,329,728 | $1,009,057 | 15.96 % | $812,375 | | | | | | History of Two Sigma Investments Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Ubs Ag | Institution | 182,574 | Added More | 780 | 0.42 % | $6,152,744 | $7,134,992 | $982,248 | 15.96 % | $4,196 | | | | | | History of Ubs Ag Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Ubs Global Asset Management Americas Inc | Institution | 323,600 | Added More | 25,400 | 8.51 % | $10,905,320 | $12,646,288 | $1,740,968 | 15.96 % | $136,652 | | | | | | History of Ubs Global Asset Management Americas Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Usquehanna International Group Llp | Institution | 234,722 | Sold Some | -20,105 | -7.88 % | $7,910,131 | $9,172,936 | $1,262,804 | 15.96 % | $-108,165 | | | | | | History of Usquehanna International Group Llp Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR/A | Vanguard Group Inc | Institution | 2,609,850 | Added More | 145,142 | 5.88 % | $87,951,945 | $101,992,938 | $14,040,993 | 15.96 % | $780,864 | | | | | | History of Vanguard Group Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Wellington Management Co Llp | Institution | 225,201 | Sold Some | -540,690 | -70.59 % | $7,589,274 | $8,800,855 | $1,211,581 | 15.96 % | $-2,908,912 | | | | | | History of Wellington Management Co Llp Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | World Asset Management Inc | Institution | 10,149 | Added More | 416 | 4.27 % | $342,021 | $396,623 | $54,602 | 15.96 % | $2,238 | | | | | | History of World Asset Management Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-15 | 2009-03-31 | 13F-HR | Zacks Investment Management | Institution | 16,081 | Sold Some | -2,676 | -14.26 % | $541,930 | $628,445 | $86,516 | 15.96 % | $-14,397 | | | | | | History of Zacks Investment Management Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-14 | 2009-03-31 | 13F-HR | Aronson And Johnson And Ortiz Lp | Institution | 41,100 | No Change | 0 | 0 % | $1,344,792 | $1,606,188 | $261,396 | 19.43 % | $0 | | | | | | History of Aronson And Johnson And Ortiz Lp Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-14 | 2009-03-31 | 13F-HR | Barclays Global Investors Uk Holdings Ltd | Institution | 4,342,986 | Sold Some | -41,494 | -0.94 % | $142,102,502 | $169,723,893 | $27,621,391 | 19.43 % | $-263,902 | | | | | | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-14 | 2009-03-31 | 13F-HR | Bennett Lawrence Management L L C | Institution | 163,350 | Added More | 44,150 | 37.03 % | $5,344,812 | $6,383,718 | $1,038,906 | 19.43 % | $280,794 | | | | | | History of Bennett Lawrence Management L L C Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-14 | 2009-03-31 | 13F-HR | Bnp Paribas Arbitrage Sa | Institution | 11,993 | New Holding | 11,993 | 100 % | $392,411 | $468,686 | $76,275 | 19.43 % | $76,275 | | | | | | History of Bnp Paribas Arbitrage Sa Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-14 | 2009-03-31 | 13F-HR | Capital Fund Management S A | Institution | | Sold All | -800 | -100 % | | | | 19.43 % | $-5,088 | | | | | | History of Capital Fund Management S A Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-14 | 2009-03-31 | 13F-HR | Credit Suisse First Boston | Institution | 42,421 | No Compare | | | $1,388,015 | $1,657,813 | $269,798 | 19.43 % | | | | | | | History of Credit Suisse First Boston Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-14 | 2009-03-31 | 13F-HR | First Mercantile Trust Co | Institution | 937,734 | Added More | 80,031 | 9.33 % | $30,682,656 | $36,646,645 | $5,963,988 | 19.43 % | $508,997 | | | | | | History of First Mercantile Trust Co Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-14 | 2009-03-31 | 13F-HR | Goldman Sachs Group Inc | Institution | 369,195 | Sold Some | -394,429 | -51.65 % | $12,080,060 | $14,428,141 | $2,348,080 | 19.43 % | $-2,508,568 | | | | | | History of Goldman Sachs Group Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-14 | 2009-03-31 | 13F-HR | Hillsdale Investment Management Inc | Institution | 1,000 | Sold Some | -400 | -28.57 % | $32,720 | $39,080 | $6,360 | 19.43 % | $-2,544 | | | | | | History of Hillsdale Investment Management Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-14 | 2009-03-31 | 13F-HR | Investec Asset Management Ltd | Institution | 380,730 | Sold Some | -838 | -0.21 % | $12,457,486 | $14,878,928 | $2,421,443 | 19.43 % | $-5,330 | | | | | | History of Investec Asset Management Ltd Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-14 | 2009-03-31 | 13F-HR | Jacobs Levy Equity Management Inc | Institution | | Sold All | -7,900 | -100 % | | | | 19.43 % | $-50,244 | | | | | | History of Jacobs Levy Equity Management Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-14 | 2009-03-31 | N-Q | Mainstay Vp Series Fund Inc-Vp Mid Cap Growth Portfolio | Mid-Cap Growth | 39,600 | New Holding | 39,600 | 100 % | $1,295,712 | $1,547,568 | $251,856 | 19.43 % | $251,856 | | | | | | History of Mainstay Vp Series Fund Inc-Vp Mid Cap Growth Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-14 | 2009-03-31 | N-Q | Mainstay Vp Series Fund Inc-Vp Small Cap Growth Portfolio | Small-Cap Growth | 31,700 | Added More | 5,100 | 19.17 % | $1,037,224 | $1,238,836 | $201,612 | 19.43 % | $32,436 | | | | | | History of Mainstay Vp Series Fund Inc-Vp Small Cap Growth Portfolio Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-14 | 2009-03-31 | 13F-HR | Martingale Asset Management L P | Institution | 39,132 | Added More | 826 | 2.15 % | $1,280,399 | $1,529,279 | $248,880 | 19.43 % | $5,253 | | | | | | History of Martingale Asset Management L P Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-14 | 2009-03-31 | 13F-HR | Next Century Growth Investors Llc | Institution | 153,588 | Added More | 19,248 | 14.32 % | $5,025,399 | $6,002,219 | $976,820 | 19.43 % | $122,417 | | | | | | History of Next Century Growth Investors Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-14 | 2009-03-31 | 13F-HR | Pioneer Investment Management Inc | Institution | 367,877 | Sold Some | -6,451 | -1.72 % | $12,036,935 | $14,376,633 | $2,339,698 | 19.43 % | $-41,028 | | | | | | History of Pioneer Investment Management Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-14 | 2009-03-31 | 13F-HR | Price T Rowe Associates Inc | Institution | 6,438,140 | Sold Some | -266,460 | -3.97 % | $210,655,941 | $251,602,511 | $40,946,570 | 19.43 % | $-1,694,686 | | | | | | History of Price T Rowe Associates Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-14 | 2009-03-31 | 13F-HR | Profund Advisors Llc | Institution | 17,640 | Sold Some | -7,736 | -30.48 % | $577,181 | $689,371 | $112,190 | 19.43 % | $-49,201 | | | | | | History of Profund Advisors Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-14 | 2009-03-31 | 13F-HR | Proshare Advisors Llc | Institution | 41,629 | Added More | 8,419 | 25.35 % | $1,362,101 | $1,626,861 | $264,760 | 19.43 % | $53,545 | | | | | | History of Proshare Advisors Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-14 | 2009-03-31 | 13F-HR | Provident Investment Counsel | Institution | 187,929 | Added More | 154,840 | 467.95 % | $6,149,037 | $7,344,265 | $1,195,228 | 19.43 % | $984,782 | | | | | | History of Provident Investment Counsel Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-14 | 2009-03-31 | 13F-HR | Rbc Dain Rauscher Inc | Institution | 2,887 | Sold Some | -49,977 | -94.53 % | $94,463 | $112,824 | $18,361 | 19.43 % | $-317,854 | | | | | | History of Rbc Dain Rauscher Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-14 | 2009-03-31 | 13F-HR | Renaissance Technologies Corp | Institution | 243,876 | Added More | 36,600 | 17.65 % | $7,979,623 | $9,530,674 | $1,551,051 | 19.43 % | $232,776 | | | | | | History of Renaissance Technologies Corp Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-14 | 2009-03-31 | 13F-HR | Rodney Square Management Corp | Institution | 6,850 | Added More | 1,200 | 21.23 % | $224,132 | $267,698 | $43,566 | 19.43 % | $7,632 | | | | | | History of Rodney Square Management Corp Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-14 | 2009-03-31 | 13F-HR | Roxbury Capital Management | Institution | | Sold All | -454,560 | -100 % | | | | 19.43 % | $-2,891,002 | | | | | | History of Roxbury Capital Management Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-14 | 2009-03-31 | 13F-HR | Royal Bank Of Canada | Institution | 155 | Sold Some | -90 | -36.73 % | $5,072 | $6,057 | $986 | 19.43 % | $-572 | | | | | | History of Royal Bank Of Canada Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-14 | 2009-03-31 | 13F-HR | Royal Bank Of Scotland Group Plc | Institution | 16,330 | Added More | 47 | 0.28 % | $534,318 | $638,176 | $103,859 | 19.43 % | $299 | | | | | | History of Royal Bank Of Scotland Group Plc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-14 | 2009-03-31 | 13F-HR | Ubs Oconnor Llc | Institution | 152,118 | New Holding | 152,118 | 100 % | $4,977,301 | $5,944,771 | $967,470 | 19.43 % | $967,470 | | | | | | History of Ubs Oconnor Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-14 | 2009-03-31 | 13F-HR | Us Bancorp De | Institution | 3,802 | Sold Some | -1,293 | -25.37 % | $124,401 | $148,582 | $24,181 | 19.43 % | $-8,223 | | | | | | History of Us Bancorp De Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-14 | 2009-03-31 | 13F-HR | Westfield Capital Management Co Llc | Institution | 3,323,576 | Sold Some | -427,835 | -11.40 % | $108,747,407 | $129,885,350 | $21,137,943 | 19.43 % | $-2,721,031 | | | | | | History of Westfield Capital Management Co Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-14 | 2009-03-31 | 13F-HR | Wexford Capital Llc | Institution | 33,132 | Added More | 3,100 | 10.32 % | $1,084,079 | $1,294,799 | $210,720 | 19.43 % | $19,716 | | | | | | History of Wexford Capital Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-13 | 2009-03-31 | 13F-HR | American Century Companies Inc | Institution | 1,744,065 | Added More | 64,294 | 3.82 % | $58,705,228 | $68,158,060 | $9,452,832 | 16.10 % | $348,473 | | | | | | History of American Century Companies Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-13 | 2009-03-31 | 13F-HR | Barclays Plc | Institution | 67,734 | Sold Some | -147,283 | -68.49 % | $2,279,926 | $2,647,045 | $367,118 | 16.10 % | $-798,274 | | | | | | History of Barclays Plc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-13 | 2009-03-31 | 13F-HR | Commonwealth Of Pennsylvania Public School Empls Retrmt Sy | Institution | | Sold All | -81,930 | -100 % | | | | 16.10 % | $-444,061 | | | | | | History of Commonwealth Of Pennsylvania Public School Empls Retrmt Sy Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-13 | 2009-03-31 | 13F-HR/A | Duquesne Capital Management L L C | Institution | 25,000 | New Holding | 25,000 | 100 % | $841,500 | $977,000 | $135,500 | 16.10 % | $135,500 | | | | | | History of Duquesne Capital Management L L C Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-13 | 2009-03-31 | 13F-HR | First Quadrant L P | Institution | 95,990 | Added More | 56,150 | 140.93 % | $3,231,023 | $3,751,289 | $520,266 | 16.10 % | $304,333 | | | | | | History of First Quadrant L P Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-13 | 2009-03-31 | 13F-HR | Fortaleza Asset Management Inc | Institution | 41,731 | Added More | 11,375 | 37.47 % | $1,404,665 | $1,630,847 | $226,182 | 16.10 % | $61,653 | | | | | | History of Fortaleza Asset Management Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-13 | 2009-03-31 | 13F-HR | Fortis Investments Management Usa Inc | Institution | 134,600 | New Holding | 134,600 | 100 % | $4,530,636 | $5,260,168 | $729,532 | 16.10 % | $729,532 | | | | | | History of Fortis Investments Management Usa Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-13 | 2009-03-31 | 13F-HR | Globeflex Capital L P | Institution | 43,300 | Added More | 500 | 1.16 % | $1,457,478 | $1,692,164 | $234,686 | 16.10 % | $2,710 | | | | | | History of Globeflex Capital L P Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-13 | 2009-03-31 | 13F-HR | Goodman And Company Investment Counsel Ltd | Institution | 500,000 | New Holding | 500,000 | 100 % | $16,830,000 | $19,540,000 | $2,710,000 | 16.10 % | $2,710,000 | | | | | | History of Goodman And Company Investment Counsel Ltd Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-13 | 2009-03-31 | 13F-HR | Great West Life Assurance Co | Institution | | Sold All | -56,000 | -100 % | | | | 16.10 % | $-303,520 | | | | | | History of Great West Life Assurance Co Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-13 | 2009-03-31 | 13F-HR | Independent Portfolio Consultants Inc | No Data | 8,680 | New Holding | 8,680 | 100 % | $292,169 | $339,214 | $47,046 | 16.10 % | $47,046 | | | | | | History of Independent Portfolio Consultants Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-13 | 2009-03-31 | 13F-HR | J P Morgan Chase And Co | Institution | 1,172,278 | Sold Some | -44,177 | -3.63 % | $39,458,877 | $45,812,624 | $6,353,747 | 16.10 % | $-239,439 | | | | | | History of J P Morgan Chase And Co Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-13 | 2009-03-31 | 13F-HR | Julius Baer Investment Management Llc | Institution | 2,330 | Sold Some | -570 | -19.65 % | $78,428 | $91,056 | $12,629 | 16.10 % | $-3,089 | | | | | | History of Julius Baer Investment Management Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-13 | 2009-03-31 | 13F-HR | Marshall Ilsley Corp | Institution | 125,804 | No Compare | | | $4,234,563 | $4,916,420 | $681,858 | 16.10 % | | | | | | | History of Marshall Ilsley Corp Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-13 | 2009-03-31 | 13F-HR | Neuberger Berman Llc | Institution | 381,700 | Added More | 150,200 | 64.88 % | $12,848,022 | $14,916,836 | $2,068,814 | 16.10 % | $814,084 | | | | | | History of Neuberger Berman Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-13 | 2009-03-31 | 13F-HR | Overeign Asset Management Corp | Institution | 33,820 | New Holding | 33,820 | 100 % | $1,138,381 | $1,321,686 | $183,304 | 16.10 % | $183,304 | | | | | | History of Overeign Asset Management Corp Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-13 | 2009-03-31 | 13F-HR | Pier Capital Llc | Institution | 26,416 | New Holding | 26,416 | 100 % | $889,163 | $1,032,337 | $143,175 | 16.10 % | $143,175 | | | | | | History of Pier Capital Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-13 | 2009-03-31 | 13F-HR | Rbc Asset Management Inc | Institution | 21,000 | No Change | 0 | 0 % | $706,860 | $820,680 | $113,820 | 16.10 % | $0 | | | | | | History of Rbc Asset Management Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-13 | 2009-03-31 | 13F-HR | Rigel Capital Llc | Institution | 16,970 | Sold Some | -4,605 | -21.34 % | $571,210 | $663,188 | $91,977 | 16.10 % | $-24,959 | | | | | | History of Rigel Capital Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-13 | 2009-03-31 | 13F-HR | Signaturefd Llc | No Data | 20 | No Change | 0 | 0 % | $673 | $782 | $108 | 16.10 % | $0 | | | | | | History of Signaturefd Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-13 | 2009-03-31 | 13F-HR | Technical Financial Services Llc | Institution | 14,275 | New Holding | 14,275 | 100 % | $480,497 | $557,867 | $77,371 | 16.10 % | $77,371 | | | | | | History of Technical Financial Services Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-13 | 2009-03-31 | 13F-HR | Tokum Capital Management Lp | Institution | 95,167 | Added More | 16,984 | 21.72 % | $3,203,321 | $3,719,126 | $515,805 | 16.10 % | $92,053 | | | | | | History of Tokum Capital Management Lp Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-13 | 2009-03-31 | 13F-HR | Uffolk Capital Management Llc | Institution | 14,000 | Sold Some | -9,000 | -39.13 % | $471,240 | $547,120 | $75,880 | 16.10 % | $-48,780 | | | | | | History of Uffolk Capital Management Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-13 | 2009-03-31 | 13F-HR | Untrust Banks Inc | Institution | 173,021 | Sold Some | -14,209 | -7.58 % | $5,823,887 | $6,761,661 | $937,774 | 16.10 % | $-77,013 | | | | | | History of Untrust Banks Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-12 | 2009-05-11 | 4 | Keiser David W | Insider | 159,546 | Sold Some | -7,800 | -4.66 % | $5,539,437 | $6,235,058 | $695,621 | 12.55 % | $-34,008 | X | | | | | History of Keiser David W Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-12 | 2009-03-31 | 13F-HR | Ameriprise Financial Inc | Institution | 193,670 | Added More | 26,330 | 15.73 % | $6,724,222 | $7,568,624 | $844,401 | 12.55 % | $114,799 | | | | | | History of Ameriprise Financial Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-12 | 2009-03-31 | 13F-HR | Bbt Capital Management Inc | Institution | 240,000 | Added More | 65,000 | 37.14 % | $8,332,800 | $9,379,200 | $1,046,400 | 12.55 % | $283,400 | | | | | | History of Bbt Capital Management Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-12 | 2009-03-31 | 13F-HR | Columbia Wanger Asset Management Lp | Institution | 4,083,700 | Sold Some | -7,400 | -0.18 % | $141,786,064 | $159,590,996 | $17,804,932 | 12.55 % | $-32,264 | | | | | | History of Columbia Wanger Asset Management Lp Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-12 | 2009-03-31 | 13F-HR | Comerica Bank | Institution | 13,105 | Added More | 1,355 | 11.53 % | $455,006 | $512,143 | $57,138 | 12.55 % | $5,908 | | | | | | History of Comerica Bank Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-12 | 2009-03-31 | 13F-HR | Federated Investors Inc | Institution | 49,706 | Sold Some | -88,214 | -63.96 % | $1,725,792 | $1,942,510 | $216,718 | 12.55 % | $-384,613 | | | | | | History of Federated Investors Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-12 | 2009-03-31 | 13F-HR | Franklin Resources Inc | Institution | 64,600 | Sold Some | -29,700 | -31.49 % | $2,242,912 | $2,524,568 | $281,656 | 12.55 % | $-129,492 | | | | | | History of Franklin Resources Inc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-12 | 2009-03-31 | 13F-HR | G Americas Securities Llc | Institution | | Sold All | -21,052 | -100 % | | | | 12.55 % | $-91,787 | | | | | | History of G Americas Securities Llc Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-12 | 2009-03-31 | 13F-HR | Hartford Investment Management Co | Institution | 163,407 | Added More | 17,650 | 12.10 % | $5,673,491 | $6,385,946 | $712,455 | 12.55 % | $76,954 | | | | | | History of Hartford Investment Management Co Ownership Of Alexion Pharmaceuticals Inc |
| 2009-05-12 | 2009-03-31 | 13F-H |